Dense deposit disease and the factor H H402 allele

Keith K. Lau; Richard J. Smith; Peter C. Kolbeck; Lavjay Butani

doi:10.1007/s10157-008-0031-z

Dense deposit disease and the factor H H402 allele

Keith K. Lau, Richard J. Smith, Peter C. Kolbeck, Lavjay Butani

Pediatric Nephrology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Herein, we describe the case of an 8-year-old boy who presented with a nephritic nephrotic syndrome. His laboratory investigation was significant for a persistently low serum complement 3 level. A renal biopsy was performed, based on which, he was diagnosed with dense deposit disease/membranoproliferative glomerulonephritis type II (DDD/MPGN II). He was treated with alternate-day oral corticosteroids, angiotensin-converting enzyme (ACE) inhibitors and tacrolimus. Factor H mutational analysis showed the Y402H and I62V allele polymorphisms. The purpose of our report is to discuss the association of the H402 allele variant of factor H with the DDD/MPGN II phenotype and its possible therapeutic implications.

Original language	English (US)
Pages (from-to)	228-232
Number of pages	5
Journal	Clinical and Experimental Nephrology
Volume	12
Issue number	3
DOIs	https://doi.org/10.1007/s10157-008-0031-z
State	Published - Jun 2008

Keywords

C3 nephritic factor
Dense deposit disease
Factor H
MPGN

ASJC Scopus subject areas

Nephrology

Access to Document

10.1007/s10157-008-0031-z

Cite this

@article{1de55634666b4b70b920445831a1ec51,

title = "Dense deposit disease and the factor H H402 allele",

abstract = "Herein, we describe the case of an 8-year-old boy who presented with a nephritic nephrotic syndrome. His laboratory investigation was significant for a persistently low serum complement 3 level. A renal biopsy was performed, based on which, he was diagnosed with dense deposit disease/membranoproliferative glomerulonephritis type II (DDD/MPGN II). He was treated with alternate-day oral corticosteroids, angiotensin-converting enzyme (ACE) inhibitors and tacrolimus. Factor H mutational analysis showed the Y402H and I62V allele polymorphisms. The purpose of our report is to discuss the association of the H402 allele variant of factor H with the DDD/MPGN II phenotype and its possible therapeutic implications.",

keywords = "C3 nephritic factor, Dense deposit disease, Factor H, MPGN",

author = "Lau, {Keith K.} and Smith, {Richard J.} and Kolbeck, {Peter C.} and Lavjay Butani",

year = "2008",

month = jun,

doi = "10.1007/s10157-008-0031-z",

language = "English (US)",

volume = "12",

pages = "228--232",

journal = "Clinical and Experimental Nephrology",

issn = "1342-1751",

publisher = "Springer Japan",

number = "3",

}

TY - JOUR

T1 - Dense deposit disease and the factor H H402 allele

AU - Lau, Keith K.

AU - Smith, Richard J.

AU - Kolbeck, Peter C.

AU - Butani, Lavjay

PY - 2008/6

Y1 - 2008/6

N2 - Herein, we describe the case of an 8-year-old boy who presented with a nephritic nephrotic syndrome. His laboratory investigation was significant for a persistently low serum complement 3 level. A renal biopsy was performed, based on which, he was diagnosed with dense deposit disease/membranoproliferative glomerulonephritis type II (DDD/MPGN II). He was treated with alternate-day oral corticosteroids, angiotensin-converting enzyme (ACE) inhibitors and tacrolimus. Factor H mutational analysis showed the Y402H and I62V allele polymorphisms. The purpose of our report is to discuss the association of the H402 allele variant of factor H with the DDD/MPGN II phenotype and its possible therapeutic implications.

AB - Herein, we describe the case of an 8-year-old boy who presented with a nephritic nephrotic syndrome. His laboratory investigation was significant for a persistently low serum complement 3 level. A renal biopsy was performed, based on which, he was diagnosed with dense deposit disease/membranoproliferative glomerulonephritis type II (DDD/MPGN II). He was treated with alternate-day oral corticosteroids, angiotensin-converting enzyme (ACE) inhibitors and tacrolimus. Factor H mutational analysis showed the Y402H and I62V allele polymorphisms. The purpose of our report is to discuss the association of the H402 allele variant of factor H with the DDD/MPGN II phenotype and its possible therapeutic implications.

KW - C3 nephritic factor

KW - Dense deposit disease

KW - Factor H

KW - MPGN

UR - http://www.scopus.com/inward/record.url?scp=44149123115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44149123115&partnerID=8YFLogxK

U2 - 10.1007/s10157-008-0031-z

DO - 10.1007/s10157-008-0031-z

M3 - Article

C2 - 18224273

AN - SCOPUS:44149123115

VL - 12

SP - 228

EP - 232

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 3

ER -

Dense deposit disease and the factor H H402 allele

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this